학술논문
Should We Discontinue Dopamine Agonist Therapy after 3 or 5 Years in Patients with Macroprolactinoma and Microprolactinoma, as the Majority Have Recurrence of Hyperprolactinaemia within 12 Months?
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
0163769X